Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...
After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...
Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...
Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...
It was about 2 in the morning when Claudilio Cruz, a member of a road crew spreading asphalt on U.S. 1 in the affluent Miami suburb of Pinecrest, heard frantic honking. When he looked up he was ...
The 2025 Florida Python Challenge yielded 294 Burmese pythons, the most since the challenge began. Taylor Stanberry won the Ultimate Grand Prize of $10,000 for capturing 60 pythons. A total of 294 ...
A large albino Burmese python, nicknamed "Nanners," was captured in Prosperity, South Carolina, after weeks on the loose. Local resident Warren Gallman and friends caught the snake, which had been ...
The 2025 Python Challenge removed a record 294 invasive Burmese pythons from Florida ecosystems. The winner, Taylor Stanberry, removed 60 Burmese pythons and took home a $10,000 prize. The 10-day ...
Residents of downtown Los Angeles were recently shocked to discover a gigantic 20-foot python in a dumpster near an apartment complex. Locals originally thought the snake was fake, but further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results